Skip to main content

Month: April 2022

Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2022 Highlight Potential of ETB Approach

Presentations from multiple pipeline programs feature clinical and preclinical data demonstrating the unique biology of Molecular Templates’ technology AUSTIN, Texas, April 12, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc., (Nasdaq: MTEM, “Molecular Templates” or “MTEM”) a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), reviews highlights from the six poster presentations on its pipeline programs that were presented at the American Association of Cancer Research (AACR) Annual Meeting 2022, taking place April 8 – April 13, 2022 at the Ernest N. Morial Convention Center in New Orleans, LA. Copies of the posters presented at AACR can be found in the Investors section of Molecular Templates’ website under Presentations. “We...

Continue reading

BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress due to COVID-19

Phase I/II trial initiation expected in 3Q 2022 SUNNYVALE, Calif., April 12, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Investigational New Drug (IND) application for BCDA-04, a proprietary allogeneic mesenchymal cell (MSC) population that is Neurokinin-1 receptor positive (NK1R+). This allows BioCardia to initiate its First-in-Human Phase I/II trial in adult patients recovering from Acute Respiratory Distress Syndrome (ARDS) due to COVID-19, with trial initiation expected in the third quarter of 2022. The first part of the clinical trial will evaluate increasing doses of the NK1R+ MSCs and the optimal dose...

Continue reading

TOWER ONE SECURES CONTRACT TO BUILD SITES WITH TELEFONICA (ECUADOR)

Miami, Florida, April 12, 2022 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (OTCQB: TOWTF) (CSE: TO) (Frankfurt: 1P3N) (“Tower One” or the “Company”). Tower One, through its subsidiary in Ecuador is pleased to announce a new contract with Telefonica (NYSE: TEF) – to build Tower Sites and to finance equipment. This transaction has a CAPEX requirement of $18M USD. Each tower site is a build to suit (BTS) as requested by Telefonica. Alejandro Ochoa, Tower One Wireless CEO, said: “We are very happy to secure this transaction giving Tower One Wireless its first point of support in Ecuador. As part of this new project, we have hired a local team of experience that has built locally previously. In addition to this award, the company has also secured contracts with the other mobile network operators in the country. We expect this project...

Continue reading

VSBLTY, RADARAPP SIGN MULTI-YEAR CONTRACT WITH MAJOR MEXICAN TELECOM CARRIER

VSBLTY AI Logic to be Installed in 20,000 Cameras Over Four-Year Period Philadelphia, PA, April 12, 2022 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt 5VS) (OTC: VSBGF) (“VSBLTY”), a leading software provider of security and retail analytics technology, and RADARApp, a Smart City Solutions provider, today announced that they, together with other ecosystem partners, have signed a contract with a major Mexican telecommunications carrier to actively market their integrated surveillance and advanced security technology. The contract calls for the technology to be installed in more than 20,000 cameras over the next four years. The smart cameras, using VSBLTY artificial intelligence technology and the industry’s most advanced analytics, will enable the creation of a WiFi6-based surveillance network in many...

Continue reading

Clover To Present at World Vaccine Congress Washington 2022

SHANGHAI, China, April 12, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced that Igor Smolenov, Senior Vice President, Global Clinical Development, will deliver a presentation at the World Vaccine Congress Washington 2022. The presentation will include data on SCB-2019 (CpG 1018/Alum), Clover’s adjuvanted protein-based COVID-19 vaccine candidate. Presentation details are as follows: Workshop Title: Vaccine TechnologyPresenter: Igor Smolenov, SVP, Global Clinical Development, Clover BiopharmaceuticalsPresentation Title: Clover’s adjuvanted protein-based vaccine: efficacy against SARS-CoV-2 variants and duration of protectionSession Date and Time: April 18, 2022,...

Continue reading

Karl Hoenecke Joins GZ6G Technologies as Director of Operations and Sales

LAS VEGAS, NV, April 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – GZ6G Technologies Corp. (OTCQB: GZIC), an enterprise smart solutions provider for cities, stadiums, universities, and other large venues, today announced their newest member to the executive team, Karl Hoenecke. As the Director of Operations and Sales, he will oversee the Networks division of GZ6G and sales staff. Hoenecke brings his vast knowledge in sales and acquisitions to the team sharing GZ6G’s emerging tech vision of “what’s next, not just what we can do today.” Hoenecke joins GZ6G from TeamLogic IT, a national franchisor of Managed Service Providers (MSP), where he served as Vice President of Business Development. He previously held various operational and sales positions at New Horizons Computer Learning Centers, Starbucks, Great Clips, Inc. and Enterprise...

Continue reading

Organisation of the Board of Directors of Eezy Plc

EEZY PLC — STOCK EXCHANGE RELEASE — 12 APRIL 2022 AT 13.30 Organisation of the Board of Directors of Eezy Plc Eezy Plc’s annual general meeting (AGM) was held today on 12 April 2022. Tapio Pajuharju, Kati Hagros, Liisa Harjula, Timo Mänty, Paul-Petteri Savolainen, Jarno Suominen and Mika Uotila were re-elected as the members of the Board of Directors. Mikko Wirén was elected as a new member. In a formation meeting of the Board, held after the AGM, Tapio Pajuharju was elected to continue as the chairman. Liisa Harjula (chair), Jarno Suominen and Kati Hagros will continue as the Audit committee. The Board decided to establish a Human Resources Committee which assists the Board by preparing matters pertaining to the remuneration and nomination of the Company’s CEO and other management, as well as the Company’s remuneration...

Continue reading

Radisson Hotel Group debuts in Ghana with the opening of Number One Oxford Street Hotel & Suites, a member of Radisson Individuals

Restaurant at Number One Oxford Street Hotel & Suites a member of Radisson Individuals Restaurant at Number One Oxford Street Hotel & Suites a member of Radisson IndividualsApartment at Number One Oxford Street Hotel & Suites a member of Radisson Individuals Apartment at Number One Oxford Street Hotel & Suites a member of Radisson IndividualsRadisson Hotel Group debuts in Ghana with the opening of Number One Oxford Street Hotel & Suites, a member of Radisson Individuals Radisson Hotel Group is proud to announce its debut in Ghana with the opening of Number One Oxford Street Hotel & Suites, a member of Radisson Individuals. In partnership with Belfast City Management, a wholly-owned subsidiary of Kwarleyz Group, the hotel also marks the second Radisson Individuals hotel opening in Africa within the last...

Continue reading

Tyson Foods Commits More Than $1 Million to Expand Legal and Citizenship Support for Team Members

Company partners with non-profit groups to provide support at more locations SPRINGDALE, Ark., April 12, 2022 (GLOBE NEWSWIRE) — Tyson Foods (NYSE: TSN) has committed more than $1 million to support its many team members who are immigrants to the United States. The company’s U.S. based workforce is comprised of team members from more than 160 countries and collectively speak more than 50 languages. The Tyson Immigration Partnership (TIP) helps provide these team members with legal services and acquire U.S. citizenship. The program, which has been supporting seven Tyson facilities over the past year, will now serve 40 company locations in 14 states.   Tyson Foods works with Immigrant Connection and, in the company’s home state, Arkansas Immigrant Defense, both of which are non-profit groups that help provide immigrants with legal...

Continue reading

Comstock Announces LiNiCo’s New President

VIRGINIA CITY, Nev., April 12, 2022 (GLOBE NEWSWIRE) — Comstock Mining Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced the appointment of Leonardo Riera, as president of LINICO Corporation, its electrification products subsidiary, located in the Tahoe Reno Industrial Center, Nevada. Mr. Riera is an experienced chief executive, with global experience in the renewable energy, manufacturing, mergers and acquisition, capital markets and financial services industries. Mr. Riera spent a decade as the Executive Director and Country Head for Bankers Trust Company in Venezuela, overseeing all of their investment banking and broker-dealer operations. Mr. Riera was the founder and chief executive office of an engineering-centric, clean waste-to-energy company with projects in three countries. Mr. Riera was also the Asset...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.